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Serial Number 
THE UNIVERSITY OF RHODE ISLAND 
Kingston, Rhode Island 
FACULTY SENATE 
BILL 
Adopted by the Faculty Senate 
#91-92--23 
TO: President Robert L. Carothers 
FROM: Chairperson of the Faculty Senate 
1. The attached BILL, titled The Two Hundred and Eighty-Sixth 
Report of the Curricular Affairs Committee: Joint Report of the 
Curricular Affairs Committee and the Graduate Council on the 
Doctor of Pharmacy Degree 
is forwarded for your consideration. 
2. The original and two copies for your use are included. 
3. This BILL was adopted by vote of the Faculty Senate on March 26, 1992 
(date) 
4. After considering this bill, will you please indicate your approval 
or disapproval. Return the original or forward it to the Board of 
Governors, completing the appropriate endorsement below. 
5. In accordance with Section 10, paragraph 4 of the Senate's By-Laws, 
this bill will become effective April 16, 1992 , 
three weeks after Senate approval, unless: (1) specific dates for 
implementation are written into the bill; (2) you return it disapproved; 
(3) you forward it to the Board of Governors for their approval; or (4) 
the University Faculty petitions for a referendum. If the bill is 
forwarded to the Board of Governors, it will not become effective until 
approved by the Board. 
March 27, 1992 
(date) Leonard M. Kahn 
Chairperson of the Faculty Senate 
ENDORSEMENT 
TO: Chairperson of the Faculty Senate 
FROM: President of the University 
Returned. 
a. Approved 
b. Approved subject to final approval by Board of Governors 
c. 
I (datie) President 
Form revised 9/91 
THE UNIVERSITY OF RHODE ISLAND 
Kingston, Rhode Island 
FACULTY SENATE 
March 16, 1992 
Faculty Senate curricular Affairq Committee 
Two Hundred and Eighty- sixth Report 
Joint Report of the Curricular Affairs Committee and Graduate Council 
Proposal for Six Year Professional 
Doctor of Pharmacy Degree 
and 
Discontinuation of Two Year Graduate Doctor of Pharmacy Degree 
On December 9 , 1991, the Faculty Senate Curricular Affairs Committee 
approved the proposal from the College of Pharmacy for a new 6-Year 
Professional Doctor of Pharmacy degree. on February 7, 1992, the 
Graduate Council approved the deletion of the t .wo-year graduate Doctor 
of Pharmacy degree program effective Fall 1995, the deletion of seven 
600-level PHP courses, effective in 1994 or 1995, and the addition of 
seven new 500-level PHP courses, effective in 1994 or 1995. The 
actions by the curricular Affairs Committee and the Graduate Council 
have been held pending the budgetary impact review of the proposed Six 
Year Professional Doctor of Pharmacy Degree. 
In accordance with section 8.85.10 of the UNIVERSITY MANUAL, the 
proposal was forwarded to the Office of the Vice President for Busi-
ness and Finance with the request that a budgetary impact statement be 
prepared. Mr. J. Vernon Wyman, Assistant to the Vice President for 
Business and Finance, indicated in his memorandum dated February 25, 
1992 that the proposed 6-year professional degree program requires an 
additional $25,000 which the Office of the Provost will ensure "is 
incorporated into the 1993- 94 Budget Allocation if the program 
receives all necessary approvals to proceed." 
Based upon Mr. Wyman's statement, the Faculty senate Executive 
Committee concluded on March 16, 1992 that the proposed 6-Year 
Professional Doctor of Pharmacy degree program does not require review 
and ranking by the new Program Review Committee because it meets the 
criteria for exemption set forth in section 8.85.24 of the UNIVERSITY 
MANUAL: 
If programs do not require the allocation of funds for 
d i rect costs , or if the program can be entirely supported by 
reprogramming existing departmental funds, or if the amount 
of general revenue funds required per year does not exceed 
the current calendar year salary of an instructor, no review 
under 8 . 85 . 20 shall be required. 
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The Report is divided into two sections . Section I is the Report of 
the Curricular Affairs Committee on the Six Year Professional Doctor 
of Pharmacy degree. Section II is the Report of the Graduate Council 
on the Discontinuation of the Two Year Graduate Doctor of Pharmacy 
Degree and deletion of related 600- leveol courses and the addition of 
new 500-level courses required for the Six Year Professional Doctor of 
Pharmacy Degree Program. 
SECTION I 
The Curricular Affairs Committee recommends that the Faculty Senate 
approve the proposal for the creation of a Six Year Professional 
Doctor of Pharmacy Degree as follows (The proposal is in the format 
required by the Board of Governors for Higher Education.) 
PROPOSAL FOR A DOCTOR OF PHARMACY (6-YEAR PROFESSIONAL) DEGREE 
A. Proqram Information 
1. 
2. 
3 . 
Name of Institution 
University of Rhode Island 
Name of administrative unit 
College of pharmacy 
Title of proposed proqram 
Doctor of Pha~acy (Pharm.D.) 
4. Intended date of program change implementation 
5. 
Fall 1994 
Anticipated date of granting first degree 
May 1996 
6. Intended location 
Kingston campus 
7. Institutional review and approval process 
College of Pharmacy Curr i culum committee 
College of Pharmacy faculty 
Faculty senate Curricular Affairs Committee 
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Approval date 
10/08/91 
10/15/91 
12/09/91 
Faculty senate 
President of the University 
summary Description 
The College of Pharmacy offers a 5-year B.S. and a 
2-year graduate Doctor of Pharmacy (Pharm.D.) degree. The 
American Council on Pharmaceutical Education (ACPE), which 
accredits the professional pharmacy degree programs, has 
issued a statement that it intends to accredit only the 
6-year entry-level pharmacy degree program by the year 2000. 
In preparation for this anticipated change this College, 
like many other Colleges of Pharmacy, has developed a 
curriculum for the 6-year degree. The current 2-year 
graduate Pharm.D . program w-ill be phased out, with the last 
class entering in the fall of 1993. The 6-year 
undergraduate Pharm.D •. program will be initiated, beginning 
with the rising 5th year students, currently enrolled in the 
B.S. (Pharmacy) program, in the fall of 1994. This degree 
option will be available to up to 12 students. The 
remaining 70 or so students will continue to pursue the B.S. 
degree. It is possible that ACPE mandate, national trends, 
and student demand may require the need to expand the 
Pharm.D . program for more than 12 students. However, under 
the currently available resources the College of Pharmacy is 
prepared to offer it to no more than 12 students. 
9. Statement of resources 
To initiate the program, as proposed in the 
accompanying course proposals, no additional faculty 
positions will be required. A new course Advanced 
Pathophysiology (PHP 561, 562), will be coordinated by our 
clinical' faculty but taught by M.D.s affiliat~i!d with the 
Brown University Program in Medicine as well as other area 
hospitals. The maximum cost of honoraria for teaching this 
a-credit course is estimated to be $50,000 per year. The 
College of Pharmacy currently pays Brown University $lo,ooo 
for allowing the 2-year graduate Pharm.D. students to take a 
medical sciences course and $12,500 as stipend ($2,500-each) 
to the five students in their second year. Discontinuation 
of the graduate degree will free up these fUnds for the new 
course. An additional $25·, 000 will be provided by the 
Provost's office. The remaining $2,500 will come from the 
College of Pharmacy endowment income. 
10. Signature of the President 
Robert L. Carothers 
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B. 
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D. 
11. Persons to be contacted during the review 
Zahir A. Shaikh 
College of Pharmacy Curriculum 
Committee 
792-2362 
Rationale 
Blair M. Lord 
Vice Provost for 
Academic Programs 
792-2447 
The proposed change in program has become necessary in 
response to the mandate issued by the accrediting agency, ACPE. 
The College of Pharmacy must initiate the new program now, not 
only to receive accreditation, but most importantly, to remain 
competitive in pharmaceutical education in the Northeast region 
as well as nationally. 
In 1977 there were only ten colleges and schools of pharmacy 
which offered the 6-year entry level program. The trend across 
the country has been to initiate 6- year entry level Pharm . D. 
programs so that in 1991, 39 schools and colleges offer this as 
either the only degree or in conjunction with the more 
traditional 5- year B.S. degree. 
Institutional Role 
The University of Rhode Island assumed the resources and the 
responsibilities of the Rhode Island College of Pharmacy and 
Allied Sciences in 1957. Since then the University has been a 
significant factor in pharmaceutical education in the United 
States. 
The University has supported and in turn been enhanced by 
its College of Pharmacy. It is clearly a part of the long range 
objectives of the University to maintain a program of study in 
pharmacy which will be compatible with the institute's objectives 
and at the same time allow graduates the opportunity to become 
registered pharmacists and to practice pharmacy in Rhode Island 
as well as the other states . For reciprocity with other states 
to continue, it is essential to be an accredited.program of the 
ACPE. 
Interinstitutional Considerations 
The University of Rhode Island is the only institution in 
the State that offers pharmacy degrees. Therefore , the proposed 
program will have no impact on other educational institutions in 
Rhode Island. Furthermore, like the existing B. S. and graduate 
Pharm.D. degree programs, the proposed program will also be 
available to the NEBHE students. It is clear that transfer into 
'a program of study in pharmacy from other state-supported 
institutions of higher education will continue as per the system 
articulation agreement. 
-24 -
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B. content 
Please see attached curriculum and Section II for new 
500-level courses. 
F. Evaluation 
As has been the case, the program will be monitored on a 
continuous basis. It is expected that there will be changes in 
the program on a year-to-year basis and that three years after 
initiation, there will be a formal appraisal by .the faculty with 
outside experts. 
In November 1991, when the scheduled self-study and the ACPE 
visitations ' teams met to evaluate our entry level programs, the 
proposed program was reviewed favorably at that time. 
It is usual that the ACPE will also require an evaluation 
and report on quality and progress three or four years into the 
program. This follow up will lead to full accreditation of the 
six-year entry level Pharm.D. program. 
SBC'l'IOII II 
At its Meeting No ; 295 held on February 7, 1992, the Graduate Council 
considered and approved the following curricular matters which are now 
submitted to the Faculty Senate for confirmation. 
College of Pharmacy 
A. Discontinuation of the two-year graduate Doctor of Pharmacy 
program effective Fall 1995 . 
B. Deletion 
PHP 611, 612: Advanced Therapeutics 
(effective Fall 1994) 
PHP 671, 672: Integrated Medical Sciences I, II 
(effective Fall 1994) 
PHP 681, 682: Clinical Pharmacy Seminar I, II 
(effective Fall 1995) 
PHP 690: Advanced Clinical Clerkship 
(effective Fall 1995) 
q ri 
~) :jftl "( 
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c . ADD (New) 
PHP 51i, 512 Advanced Pharmacotherapeutics (I and II , 3 each) The 
clinical use of medications in a disease-oriented approach. The 
basic concepts of pharmacology, pharmacy, pathophysiology, and 
biochemistry will be correlated to the treatment -of disease. 
Must be taken concurrently with 561, 562. Pre: fifth year 
standing in the Doctor of Pharmacy program or by special 
permission of the instructor. Mattea and Staff (Effective Fall 
1994) 
PHP 561, 562 Advanced Human Pathophysiology (I and II, 4 each) 
The etiology , epidemiology, pathology, and clinical laboratory 
manifestation of diseases occurring in man . This intensive 
course will be taught in a biomedical format. (Lee . 4) Pre: 
fifth year standing in the Doctor of Pharmacy program , or by 
special permission of the course instructor. Owens and Staff 
(Effective Fall 1g94) 
PHP 581 , 582 Clinical Pharmacy Seminar (I and II , 1) 
Presentations made by students on appropriate advanced clinical 
pharmacy topics. (Sem.) Pre: fifth or sixth year standing in 
the Doctor of Pharmacy program or by special permission of the 
instructor. Dudley and staff (Effective Fall 1994) 
PHP 590 Advanced Clinical Pharmacy Clerkship (I and II, 5) 
Through direct clinical contact, students will learn how to 
provide optimal pharmacotherapy for patients. This is 
accomplished by collecting and interpreting data to design, 
recommend, implement, and modify patient specific pharmacotherapy 
in collaboration with other health professionals . (Five credits 
taken five times for a total of 25 credits.) Pre: sixth year 
standing in the Doctor of Pharmacy program, or by special · 
permission of the instructor. Owens and Staff (Effective Fall 
1995) 
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DOCTOR OF PHARMACY 
(Pharm.D.) 
1be six-year entry-level Doctor of Pharmacy (Phann.D.) professional degree program will be initiated in the fall of 1994. 
Students who are enrolled in the B.S. (Pharmacy) degree program at the Colk&e of Pharmacy, Unjvcrsity of Rhode Island, 
must be in fBCA' ... sj.a'WiJSlJ' order to apply for _admission to the six-year propam. Applications must be received by the 
Pharm.D. ~rulilhiuce no later than November IS in the fall semester of the student's fourth year. Individuals 
holding a B.S. (Pharmacy) degree from an ACPE-accredited program may also apply. Their application~ must be dated no 
later than October 1.5 in th<r: year prec:cdi.ng I he prospective ad:rriisSion. The College will ~pi a maximum of 12 students in 
the Pharm.D'. program. Up to 4 of those admitted may consist of .the individuals :holding the ACPE-accrcdited B.S. 
(Pharmacy) degt<e. 
Curriculum Requirements 
The course requiremenls ror lhe firsl seven semesters or the six-year Pharm. D. propam are the same as ror the fM-year B.S. 
program. See the B.S. curriculum ror details. The c:uniculum for the remaiJiiRI scmeslen is listed below. Shrdcnts are 
required to take 5 credirs of h05pital and community extemshipa.. each. In .&!ilion, C'()lftpledon of a total of riVe clinical 
rotations. 5 credits each. is required. The duntion of each clinical rotation is lix-weeb. A 'total of '1JJ7 crediiS is requi~d ror 
graduation. 
Fourth Year 
Second sc·mesrer. 19 credils 
1 PO.. 443 General Pharmacology Laboratory 
3 MOl 444 Organk Medicinal Chemistry 
3 PCL 446 General and O inical Pharmacoiogy and Todrology Ill 
2 PHP 448 Third Pa rty Prescription Programs ' 
PHP 456 Phannacorherapc:utics II 
l PIIC 461 lleallh-Reialed Supplies 
3 PIIC 462 Nonprc:.sc:riplion Drugs 
2 PUP 471 Conremporary Pharmacy Practice Laboratory 
Fiflh Year 
First semester: 17 credits 
3 PHP SJI Advanced Therapeutics I 
3 PHC 53S Applied Phannacokinelics 
4 PHP S6l Advanced Pa!hophysiology I 
PIIP 581 Seminar 
* PIIP 532 Quantitative Merhods in Pharmacy- Research 
Electives 
FiHh Year 
Second semester: 16 credits 
3 PIIP 512 Advanced Therapeutics 11 
PIIP 542 Drug Induced Diseases 
PIIP 544 Physical Assessmeni 
PHP 562 Advanced Palhophysiology II 
Eledives 
Sixth Year 
Summer session: 5 credits (one of lhe thrn rotations) 
S PHP 484 Bospital Pharmacy Ex1emship 
PIIP 485 Community Phannacy Externship 
5 PHP 590 Advanced Oinical aerk.shlp 
Sixth Year 
First semeSter: 16 credits 
1 PIIP S82 Seminar 
(three of the Jour rotations) 
5 PJ-IP 484 l-l().<l;pital Pharmacy Ex:temship 
.5 rnr 485 Communily Pharmacy l!xtemship 
20 PHP 590 Advanced Clinical Oerl:ship 
Sixth Year 
Second semester. 15 credits 
3:6 PIIP 590 Advan«d Oinical Oertship 
*Pending approval by Graduate council. 
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PROFESSIONAL PIIMMACY PROGRAMS 
fir!oiYr"' 
finiJmU'lln: 1-lrmfilJ 
J CHM 101 Gentr.JI Chemistn- l ecture 1 
I CHM 102 I.Jboratory for Ch~rnhtr,· 101 
l A Univrrsit\'-appro\'td En.s:lhh cotnmuni-
rattom course e.ucrll IIGS ]()()' 
ZOO II I Cl'ncuiZnology 
F.lecti\'~ 
Fint l't.rr 
krOJfliVtt~l(f; 17(1t,ltl1 
J CHM 112 Genml (hl'mi~rv Lrcturt 11 
CUM 114 lJbonlory for Ch~m1~1rv 112 
Mrn IJIB.JsicCalculull 
A Uni\·~rsity-appro\·t<i En~lish communi-
calions course exr~pt BGS 100' 
ZOO 121 Humom Anarolnv 
Eltc:livt . 
Strand Ytor 
First stmtftrr. I 7 crtJitJ 
CHM Z27 Otganic Ch~mhlrv Ltou1e 1 
ECN 125 Economic rrln~ 1 
4 MIC 201 lntrodooon· Mrdlul 
Mkrobiology . 
J ZOO 242 lntrodUdon.· Human 
rh}·siology . 
I ZOO 244 lnlfodurtO!'\' Uuman 
l'hysiology Llborato~· 
] Eltc:tiv~ · 
Smmdr .... 
Stcond1nMtrr.l7rrtditJ 
. J BCP Jlllntroductory Biochnnhtrv 
l CHM 228 Org~nlc Chfmistry ~r~ II 
2 CHM 226 Organi<: Chtmhtry t.a!Joratorv 
J £5T 407 Introductory 8iostllisti0 • 
6 Eltctins 
ThinlfNr 
Firtr Jtmt"sltr. 16-17 crrditJ 
2 MCH JO l'rlnripln of Mfdi<:inll 
Chemistry 
3 PC1 J27 lnttodoolon to Human 
rathophysiolon" 
2 I'HC 327 8ioph~rmKtUtk1 
3 Mfp 349 rharmacy Adminlsuatlon 
Ptlndplts 
••d 
Stm011A 
MfC 340 rhplcal Pharmacy 
PHC 350 rh~nnactutk'a l Ttc:hnoiOfY 
me 360 l'}larmKn~t;cal l.abotatory 
or 
-· ~42 Mumtxtutical An&Jysis 
TIIirdf(ltr 
!«one~ Stmnttr. 1~19 rrtditJ 
l I'CG 44.11 Gtn~r•l rhannKQKnosy 
l I'CL H-4 Gtnrral .tnd Oink" 
rhmnarology and ToalcoiOKY I 
J f'HC 128 l'h.tnnKoktnttlo 
J mr J51 rh.limumJtk.tl Law •net ElhiC'I 
'""' 
-· J MCH 142 Nl.tmxn.tk.tl Amlf'is J [ftc11VP 
or 
S«<on8 
rHC J40 !'h~lnl Nlarmacy 
MfC JSO rhanmceutk.tl TKhnology 
MfC J60 NlarmKwtical Laboratory 
Fa11t1h Ytat 
firlf St'rlftlftr./9crtJitJ 
MCH 44J Org.mir ~l~icinal ChemiW}' 
rsN H4 Nutrttlon and Di~aw: 
PCG 44 6 General Phmnacognosy 
I'CG 459i'ublir Health 
I'CI. 445 G~neral and Clinical 
l'hmnacology and To~icoloKf II 
4 rHr4UI'harm.teot~rape-utictl 
Fourtir Yw 
SKont/Jtrnnln: /9cm/;tJ 
J MCH 4H Or,~pnir Mt'dici~l Ch~mimy 
J f'CL 446 Gtnml ~nd C!iniu! 
rharmacolo~.;r and To,;kology Ill 
Z rur H8 Third-Party tiescription 
l'rogr1ms 
4 rHr 456 rhJrmacothm~utics II 
I ret ·4U Q:nml rh~rm.x:ology 
Llbomon.· 
.tnd · 
""""' 6 (l«tivn 
lifV\OLAll: _PII,\R.\fAQ PRO( iR--\\1 
2,yu rUoctor ofi'IIJ""fCyJtOhCdtj(OOIIO UCd) 
E.'.T -11)7 ln trOOurtory ll•o~l~hs hn 
PIIC SJS Arrhcd riiJ!'mJC('~tnttoC'S 
l PIIP SJO lkhJ•,out 5 ~•111 '" Clin>e,l rh1rmuy 
PIIP S-l2 Orug,-lnduccd [.l,~~.nu 
P_IIP- 611 ,\d•11nccd l'hlrmlrOihr~peutics 1 
J PIJP 612 Ad>'3 nccd Phr:m,othcqpcuhn II 
9 PI IP 671 lntcltJttd ,\lcd te i_ISncncu ·J 
PltP 6-:"2: lntc~~I C <J ,\1c<Jocal5o cnru If 
r iiP foil ! Chn•('l Phnmll")' ~m•n•~ 
fliP 662 Chnte'l PhimUC)IScmtnu 
:-1 PIIP 6\10 ''"'11nccd Chnt(~ l Clcrllhip•nd Resurrl 
~en 8 (required for 6·yea r candidates) 
MfC 462 Nonpr~scription Drugs 
l'HC 461 HeJlth-r~!att'd Suppli~ 
rHr 471 Com~mporary Pharm.tcy 
r'r2ctirt Uboratory 
I 
S-Year B.S. 
Fifth Ytcrr 
f'tntStmtSftr. 15rrtJitJ 
St\110t1A 
f'HC 462 Nonpmaiption Orurs 
MfC 461 H~alth·r~litftt Probl~mt 
PHP 471 Cont~mponry l'flarmacy 
Pt.tctke Llboutory 
.. 
S«fim18 
Mfr 484 liospital rharmacy E.ttemshlp 
rHr 48S Communlry l'ti.trmacy 
E,xternship 
5 l'tfr 490 Clininll'timnK)' Clerkship 
-ll{tfr t'Nt 
5«cnd J<"mnttf': , j t'Tnlib 
Smi0t1A 
S rHr ~8~ Hospilall'hann"'Y E.tt~mshlp 
S Mfp ~RS Community M1.1rmacy 
~~~mship 
5 PUP 490 Clininl Ph1m1K)' a~rkship 
or 
StroMB 
15 Electh·es 
12 SludeniS 
+ 
Opliona16-Year Pharm.D. 
Fiflh Yeu 
Fin1..emutcr:l1c~diu 
l PHP 511 Ad\'IIICtd Thc~rcuues I 
l PHC .SlS AJIFI~d hnmJ<ot,nctf<s 
4 PHP 561 Ad-.11nccd Plll'tophysjgioty 1 
1 -PJIP 531 ScmitUf 
• l PHP 532 Qunti llli>~ :O.Ielhods in Phnmac,· Resurr 
l Elte!r.-cl 
FiflhYcu 
StC'Ondscmuter:l6ctediU 
l PHP 512 Ad•11nccd Thc~ptut•n 11 
2 PltP 5-IZ D"'l: Induced o,uses 
I J'IIJ" 5-U Ph)'tiul As.lcs.Jmc111 
4 PHP S6l Ad>uccd l'a•hoph)'tioloc 11 
6 EteCir.-cs 
SixtPI"inf 
.Summcrsu.sion:Sctfdill(oneoflhcthl'll:crolalion•) 
$ PIIP -tS-1 flosrittiPham~lcyE.o:tcmship 
$ PIIP -1&5 Comm1.1n.1y rh1m~acy &tcm1hip 
S PIIP !i90 Ad-.'3nctd 0•11iul Onbhip 
SinhYnr 
Finr..emestcr:l6crrdill 
I PIIP !il2 Scmtnu 
(lhnofthcfOOtrrotlloon.a) 
5 Pill' -134 HO!Iptul Ph1nn1cy t'.olcmsllip 
$ Pflr .&&$ Community Pfllmllry" E.o1cm1hip 
laS 1'111' $90 Ad>11rtcd Chninl Ottbhip 
Sisti!Yur 
S«ottdumutcr. t ~ crf<Jill 
l d Pill' 5110 Ad•uccd Oirtinl Octbhip 
*Pending approval by the Graduate Council. 
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